Nasa/Getty Images
Since 2000, the International Space Station (ISS) has hosted 280 astronauts and a multitude of scientific investigations. Beyond pioneering experiments such as 3‑D printing and microbe testing, the ISS National Laboratory provides a permanent microgravity environment that has become a critical platform for cutting‑edge stem‑cell research, yielding promising insights into disease prevention and treatment.
In a 2024 analysis published in npj Microgravity, Mayo Clinic researchers Dr. Abba Zubair, M.D., Ph.D., and technologist Fay Abdul Ghani demonstrated that microgravity can unmask stem‑cell mechanisms that are invisible under Earth‑gravity conditions. Dr. Zubair has already launched three stem‑cell studies to the ISS, finding that cells cultured in space exhibit enhanced regenerative capacities compared to terrestrial counterparts.
The focus has been on adult (somatic) stem cells, which, unlike embryonic stem cells, have limited replication and differentiation potential. Growing them in the ISS’s natural microgravity environment overcomes many Earth‑based hurdles—time consumption, cost, and technical constraints—providing a more physiologically relevant setting. Early results give clinicians confidence that space‑grown stem cells could address a spectrum of age‑related ailments, including cancer, neurodegenerative disorders, and stroke.
Connect Images Rf/andrew Brookes/Getty Images
Stem cells are present in virtually all tissues, each subtype performing distinct roles. Mesenchymal stem cells (MSCs), for example, are multipotent and highly sought after for clinical applications. Mayo Clinic studies revealed that ISS‑grown MSCs more effectively reduced inflammation and modulated immune responses than their Earth‑grown counterparts.
Cardiovascular progenitor cells (CPCs) are crucial for maintaining and repairing heart muscle and vasculature. Space‑cultured CPCs hold promise for restoring tissue after myocardial infarction. Hematopoietic stem cells (HSCs)—capable of generating white and red blood cells and platelets—also displayed enhanced differentiation potential in microgravity, opening avenues for treating blood cancers. Neural stem cells, vital for brain development and repair, were found to retain viability and differentiation capacity, suggesting future therapies for central nervous system diseases.
Although still in its infancy and requiring additional funding, Dr. Zubair notes, “A broader perspective on stem‑cell applications is possible as research continues to explore the use of space to advance regenerative medicine” (Mayo Clinic).
